Short answer
COLLEGIUM PHARMACEUTICAL, INC (COLL) filed an 8-K current report with the SEC on May 15, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All eight director nominees elected through the 2027 annual meeting, preserving board continuity.
COLLEGIUM PHARMACEUTICAL, INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All eight director nominees elected through the 2027 annual meeting, preserving board continuity
- Executive compensation approved on advisory basis, with 26.3 million votes for and 1.1 million against
- Deloitte & Touche LLP ratified as independent auditor for fiscal 2026, with 28.95 million votes for
- 29.21 million of 32.41 million eligible shares participated, indicating 90.1% voting turnout
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other COLLEGIUM PHARMACEUTICAL, INC 8-K filings
Get the next COLL 8-K as it lands
Follow COLL for push alerts, or ask the research agent what this filing means.